| 15.38 Delayed Data As of May 24 |  +0.01 / +0.07%Today’s Change | 5.61 Today|||52-Week Range 25.10 | +48.03% Year-to-Date |
| Previous close | 15.37 |
| Today’s open | 15.49 |
| Day’s range | 15.33 - 16.03 |
| Volume | 3,621,656 |
| Average volume (3 months) | 12,634,062 |
| Market cap | $5.1B |
| Earnings growth (last year) | -651.95% |
| Earnings growth (this year) | +644.23% |
| Earnings growth (next 5 years) | +27.28% |
| Revenue growth (last year) | +80.42% |
| P/E ratio | 54.4 |
| Price/Sales | 319.68 |
| Price/Book | 17.72 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | +5.31 | +4.02% |
| APHAAphria Inc | +0.94 | +14.66% |
| ACBAurora Cannabis Inc | +0.06 | +0.73% |
| USNAUSANA Health Science... | +0.22 | +0.30% |
| Next reporting date | September 2, 2019 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $5.7M |
| Annual profit (last year) | -$14.6M |
| Net profit margin | -257.95% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Gorenstein |
Chief Operating Officer David Hsu |
Corporate headquarters Toronto, Ontario |
